ENVBVSMREO• 28 Days (Normalized)
ENVB vs MREO (Enveric Biosciences Inc. vs Mereo BioPharma Group plc)
Showing Closing Date Range from Aug, 14 to Sep, 11, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
ENVB Performance $1.42
-7.49%
Enveric Biosciences Inc.
Normalized Baseline0.00%
MREO Performance $0.28
-12.23%
Mereo BioPharma Group plc
Normalized Baseline0.00%
Alpha Spread Margin ENVB LEADS
+4.74%
ENVB outperforming by 4.74%
ENVBMREO
Spread Trajectory28 Days (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
ENVB MREO
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(20 dates)
| Date | ENVB Price | ENVB Gain (%) | MREO Price | MREO Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 11, 2026 | $1.42 | -7.49% | $0.28 | -12.23% | +4.74% |
| Sep 10, 2026 | $1.46 | -4.89% | $0.25 | -23.20% | +18.31% |
| Sep 09, 2026 | $1.46 | -5.21% | $0.24 | -23.82% | +18.61% |
| Sep 08, 2026 | $1.42 | -7.49% | $0.26 | -20.06% | +12.57% |
| Sep 04, 2026 | $1.39 | -9.45% | $0.25 | -21.63% | +12.18% |
| Sep 03, 2026 | $1.44 | -6.19% | $0.27 | -14.73% | +8.54% |
| Sep 02, 2026 | $1.44 | -6.19% | $0.27 | -16.30% | +10.11% |
| Sep 01, 2026 | $1.37 | -10.75% | $0.28 | -13.17% | +2.42% |
| Aug 31, 2026 | $1.37 | -10.75% | $0.27 | -16.30% | +5.55% |
| Aug 28, 2026 | $1.37 | -10.75% | $0.25 | -20.69% | +9.94% |
| Aug 27, 2026 | $1.37 | -10.75% | $0.27 | -14.73% | +3.98% |
| Aug 26, 2026 | $1.37 | -10.75% | $0.28 | -12.85% | +2.10% |
| Aug 25, 2026 | $1.46 | -4.89% | $0.28 | -11.60% | +6.71% |
| Aug 24, 2026 | $1.41 | -8.14% | $0.29 | -9.09% | +0.95% |
| Aug 21, 2026 | $1.43 | -6.84% | $0.29 | -9.09% | +2.25% |
Page 1 of 2